177Lu-EB-FAPI(Peking Union Medical College Hospital)

N/A

Report date: 2025/11/20 16:00:39

Base Information

Drug Name177Lu-EB-FAPI(Peking Union Medical College Hospital)

Drug Alias Name177Lu-EB-FAPI(Peking Union Medical College Hospital)

ClassificationRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Nuclides > Lutetium > 177LuRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionFibroblast activation protein alpha inhibitorsPositron-emission tomography enhancers

TargetsProlyl endopeptidase FAP

Therapy Area/IndicationsNeoplasm Metastasis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesPeking Union Medical College Hospital

China Registration ClassN/A

Develop Information

Active CompaniesPeking Union Medical College Hospital

Inactive CompaniesN/A

Active IndicationsNeoplasm Metastasis

Inactive IndicationsN/A

Other Information

ATC CodeN/A